How different are the costs and consequences of delayed versus immediate HIV treatment?
Date
2011
Authors
Welte A.
Hargrove J.
Delva W.
Williams B.
Stander T.
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
[No abstract available]
Description
Keywords
antiretrovirus agent, article, cost benefit analysis, early intervention, endemic disease, health care, health care cost, health care delivery, health care policy, highly active antiretroviral therapy, human, Human immunodeficiency virus infection, incidence, life expectancy, South Africa, therapy delay
Citation
South African Medical Journal
101
6
http://www.scopus.com/inward/record.url?eid=2-s2.0-79958056702&partnerID=40&md5=2b2c153df2f5399c89b6bf31e6650399
101
6
http://www.scopus.com/inward/record.url?eid=2-s2.0-79958056702&partnerID=40&md5=2b2c153df2f5399c89b6bf31e6650399